{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:30:31Z","timestamp":1790901031696,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2000,7,1]],"date-time":"2000-07-01T00:00:00Z","timestamp":962409600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Oncol Rep"],"published-print":{"date-parts":[[2000,7]]},"DOI":"10.1007\/s11912-000-0025-9","type":"journal-article","created":{"date-parts":[[2007,5,25]],"date-time":"2007-05-25T20:09:06Z","timestamp":1180123746000},"page":"322-328","source":"Crossref","is-referenced-by-count":18,"title":["The changing prognosis of melanoma"],"prefix":"10.1007","volume":"2","author":[{"given":"Antonio C.","family":"Buzaid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clay M.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"25_CR1","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1097\/00000658-197011000-00017","volume":"172","author":"A Breslow","year":"1970","unstructured":"Breslow A: Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 1970, 172:902\u2013908.","journal-title":"Ann Surg"},{"key":"25_CR2","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1200\/JCO.1997.15.3.1039","volume":"15","author":"A Buzaid","year":"1997","unstructured":"Buzaid A, Ross M, Balch C, et al.: Critical analysis of the current American Joint Committee on Cancer Staging system for cutaneous melanoma and proposal of a new staging system. J Clin Oncol 1997, 15:1039\u20131051. A comprehensive discussion of the most important prognostic factors in melanoma patients in stages I through IV, including critical analysis of the current staging system and a proposal for a new staging system for melanoma.","journal-title":"J Clin Oncol"},{"key":"25_CR3","first-page":"165","volume-title":"Cutaneous Melanoma","author":"C Balch","year":"1992","unstructured":"Balch C, Soong SJ, Shaw H, et al.: An analysis of prognostic factors in 8500 patients with cutaneous melanoma. In Cutaneous Melanoma, edn 2. Edited by Balch C, Houghton A, Milton G, et al. Philadelphia: JB Lippincott; 1992:165\u2013187.","edition":"edn 2"},{"key":"25_CR4","first-page":"383","volume":"24","author":"R Vollmer","year":"1989","unstructured":"Vollmer R: Malignant melanoma: a multivariate analysis of prognostic factors. Pathol Annu 1989, 24:383\u2013407.","journal-title":"Pathol Annu"},{"key":"25_CR5","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1002\/1097-0142(19950515)75:10<2499::AID-CNCR2820751016>3.0.CO;2-8","volume":"75","author":"P B\u00fcttner","year":"1995","unstructured":"B\u00fcttner P, Garbe C, Bertz J, et al.: Primary cutaneous melanoma: optimized cutoff points of tumor thickness and importance of Clark\u2019s level for prognostic classification. Cancer 1995, 75:2499\u20132506.","journal-title":"Cancer"},{"key":"25_CR6","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/1097-0142(19950115)75:2<478::AID-CNCR2820750211>3.0.CO;2-O","volume":"75","author":"J Carlson","year":"1995","unstructured":"Carlson J, Dickersin G, Sober A, Barnhill R: Desmoplastic neurotropic melanoma: a clinicopathologic analysis of 28 cases. Cancer 1995, 75:478\u2013494.","journal-title":"Cancer"},{"key":"25_CR7","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/(SICI)1097-0142(19980915)83:6<1128::AID-CNCR11>3.0.CO;2-7","volume":"83","author":"M Quinn","year":"1998","unstructured":"Quinn M, Crotty K, Thompson J, et al.: Desmoplastic and desmoplastic neurotropic melanoma: experience with 280 patients. Cancer 1998, 83:1128\u20131135. Report on the largest series in treatment and prognosis of desmoplastic melanoma.","journal-title":"Cancer"},{"key":"25_CR8","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1093\/jnci\/81.24.1893","volume":"81","author":"W Clark Jr","year":"1989","unstructured":"Clark WJr, Elder D, DuPont GI, et al.: Model predicting survival in stage I melanoma based on tumor progression. J Natl Cancer Inst 1989, 81:1893\u20131904.","journal-title":"J Natl Cancer Inst"},{"key":"25_CR9","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1002\/(SICI)1097-0142(19990301)85:5<1067::AID-CNCR9>3.0.CO;2-T","volume":"85","author":"D Massi","year":"1999","unstructured":"Massi D, Franchi A, Borgognoni L, et al.: Thin cutaneous malignant melanoma (<1.5 mm): identification of risk factors indicative of progression. Cancer 1999, 85:1067\u20131076.","journal-title":"Cancer"},{"key":"25_CR10","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1001\/archsurg.1992.01420040034005","volume":"127","author":"D Morton","year":"1992","unstructured":"Morton D, Wen D, Wong J, et al.: Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992, 127:392\u2013399.","journal-title":"Arch Surg"},{"key":"25_CR11","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1200\/JCO.1999.17.3.976","volume":"17","author":"J Gershenwald","year":"1999","unstructured":"Gershenwald J, Thompson W, Mansfield P, et al.: Multi-institutional lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol 1999, 17:976\u2013983. Detailed analysis of a large series on the prognostic value of sentinel node status compared with other known prognostic factors in patients with primary melanoma.","journal-title":"J Clin Oncol"},{"key":"25_CR12","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1001\/archsurg.1991.01410360031006","volume":"126","author":"P Le\u00f3n","year":"1991","unstructured":"Le\u00f3n P, Daly J, Synnestvedt M, et al.: The prognostic implications of microscopic satellites in patients with clinical stage I melanoma. Arch Surg 1991, 126:1461\u20131468.","journal-title":"Arch Surg"},{"key":"25_CR13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000226892","volume":"48","author":"D Bartkowiak","year":"1991","unstructured":"Bartkowiak D, Schumann J, Otto F, et al.: DNA flow cytometry in the prognosis of primary malignant melanoma. Oncology 1991, 48:39\u201343.","journal-title":"Oncology"},{"key":"25_CR14","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/(SICI)1097-0142(19990115)85:2<375::AID-CNCR15>3.0.CO;2-1","volume":"85","author":"T Hieken","year":"1999","unstructured":"Hieken T, Ronan S, Farolan M, et al.: Molecular prognostic markers in intermediate-thickness cutaneous malignant melanoma. Cancer 1999, 85:375\u2013382.","journal-title":"Cancer"},{"key":"25_CR15","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/ssu.2980080611","volume":"8","author":"C Balch","year":"1992","unstructured":"Balch C: Cutaneous melanoma: prognosis and treatment results worldwide. Semin Surg Oncol 1992, 8:400\u2013414.","journal-title":"Semin Surg Oncol"},{"key":"25_CR16","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/00001622-199903000-00009","volume":"11","author":"R MacKie","year":"1999","unstructured":"MacKie R: Pregnancy and exogenous hormones in patients with cutaneous malignant melanoma. Curr Opin Oncol 1999, 11:129\u2013131. Concise but comprehensive review on the impact of pregnancy and exogenous hormones on the clinical course of melanoma patients.","journal-title":"Curr Opin Oncol"},{"key":"25_CR17","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1002\/1097-0142(19891015)64:8<1612::AID-CNCR2820640810>3.0.CO;2-7","volume":"64","author":"M Landthaler","year":"1989","unstructured":"Landthaler M, Braun-Falco O, Leitl A, et al.: Excisional biopsy as the first therapeutic procedure versus primary wide local excision of malignant melanoma. Cancer 1989, 64:1612\u20131616.","journal-title":"Cancer"},{"key":"25_CR18","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1093\/jnci\/88.9.569","volume":"88","author":"A Buzaid","year":"1996","unstructured":"Buzaid A, Balch C: Polymerase chain reaction for detection of melanoma in peripheral blood: too early to assess clinical value. J Natl Cancer Inst 1996, 88:569\u2013570.","journal-title":"J Natl Cancer Inst"},{"key":"25_CR19","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1200\/JCO.1998.16.5.1760","volume":"16","author":"B Curry","year":"1998","unstructured":"Curry B, Myers K, Hersey P: Polymerase chain reaction detection of melanoma cells in the circulation: relation to clinical stage, surgical treatment, and recurrence from melanoma. J Clin Oncol 1998, 16:1760\u20131769.","journal-title":"J Clin Oncol"},{"key":"25_CR20","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1200\/JCO.1995.13.9.2361","volume":"13","author":"A Buzaid","year":"1995","unstructured":"Buzaid A, Tinoco L, Jendiroba D, et al.: Prognostic value of size of lymph node metastases in patients with cutaneous melanoma. J Clin Oncol 1995, 13:2361\u20132368.","journal-title":"J Clin Oncol"},{"key":"25_CR21","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1001\/jama.280.16.1410","volume":"280","author":"S Shivers","year":"1998","unstructured":"Shivers S, Wang X, Li W, et al.: Molecular staging of melanoma: correlation with clinical outcome. JAMA 1998, 280:1410\u20131415.","journal-title":"JAMA"},{"key":"25_CR22","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1001\/archsurg.1989.01410090061014","volume":"124","author":"A Calabro","year":"1989","unstructured":"Calabro A, Singletary S, Balch C: Patterns of relapse in 1001 consecutive patients with melanoma nodal metastases. Arch Surg 1989, 124:1051\u20131055.","journal-title":"Arch Surg"},{"key":"25_CR23","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1002\/1097-0142(19880401)61:7<1437::AID-CNCR2820610726>3.0.CO;2-Z","volume":"61","author":"S Singletary","year":"1988","unstructured":"Singletary S, Tucker S, Boddie A: Multivariate analysis of prognostic factors in regional cutaneous metastases of extremity melanoma. Cancer 1988, 61:1437\u20131440.","journal-title":"Cancer"},{"key":"25_CR24","first-page":"285","volume":"21","author":"C Brown","year":"1995","unstructured":"Brown C, Zitelli J: The prognosis and treatment of true local cutaneous recurrent malignant melanoma. Dermatol Surg 1995, 21:285\u2013290.","journal-title":"Dermatol Surg"},{"key":"25_CR25","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/00008390-199402000-00002","volume":"4","author":"R Cavaliere","year":"1994","unstructured":"Cavaliere R, Cavaliere F, Deraco M, et al.: Hyperthermic antiblastic perfusion in the treatment of stage IIIA-IIIAB melanoma patients: comparison of two experiences. Melanoma Res 1994, 4:5\u201311.","journal-title":"Melanoma Res"},{"key":"25_CR26","first-page":"111","volume":"164","author":"C Sutherland","year":"1987","unstructured":"Sutherland C, Mather F, Krementz E: Factors influencing the survival of patients with regional melanoma of the extremity treated by perfusion. Surg Gynecol Obstet 1987, 164:111\u2013118.","journal-title":"Surg Gynecol Obstet"},{"key":"25_CR27","first-page":"193","volume":"181","author":"A Barth","year":"1995","unstructured":"Barth A, Wanek L, Morton D: Prognostic factors in 1,521 melanoma patients with distant metastases. J Am Coll Surg 1995, 181:193\u2013201.","journal-title":"J Am Coll Surg"},{"key":"25_CR28","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1002\/1097-0142(19931115)72:10<3091::AID-CNCR2820721034>3.0.CO;2-V","volume":"72","author":"M Sirott","year":"1993","unstructured":"Sirott M, Bajorin D, Wong G, et al.: Prognostic factors in patients with metastatic malignant melanoma: a multivariate analysis. Cancer 1993, 72:3091\u20133098.","journal-title":"Cancer"},{"key":"25_CR29","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1200\/JCO.1999.17.6.1891","volume":"17","author":"M Deichmann","year":"1999","unstructured":"Deichmann M, Benner A, Bock M, et al.: S100-b, melanomainhibiting activity, and lactate dehydrogenase discriminate progressive from nonprogressive American Joint Committee on Cancer Stage IV melanoma. J Clin Oncol 1999, 17:1891\u20131896.","journal-title":"J Clin Oncol"},{"key":"25_CR30","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/bjc.1998.439","volume":"79","author":"A Franzke","year":"1998","unstructured":"Franzke A, Probst-Kepper M, Buer J, et al.: Elevated pretreatment serum levels of soluble vascular cell adhesion molecule 1 and lactate dehydrogenase as predictors of survival in cutaneous metastatic malignant melanoma. Br J Cancer 1998, 79:40\u201345.","journal-title":"Br J Cancer"},{"key":"25_CR31","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1200\/JCO.1998.16.9.2921","volume":"16","author":"U Keilholz","year":"1998","unstructured":"Keilholz U, Conradt C, Legha S, et al.: Results of interleukin-2-based treatment in advanced melanoma: a case record-based analysis of 631 patients. J Clin Oncol 1998, 16:2921\u20132929.","journal-title":"J Clin Oncol"},{"key":"25_CR32","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1200\/JCO.1998.16.3.1103","volume":"16","author":"O Eton","year":"1998","unstructured":"Eton O, Legha S, Moon T, et al.: Prognostic factors for survival of patients treated systemically for disseminated melanoma. J Clin Oncol 1998, 16:1103\u20131111. Report on the prognostic value of serum LDH compared with other known prognostic factors in melanoma.","journal-title":"J Clin Oncol"}],"container-title":["Current Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-000-0025-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11912-000-0025-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-000-0025-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:28:43Z","timestamp":1559435323000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11912-000-0025-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,7]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2000,7]]}},"alternative-id":["25"],"URL":"https:\/\/doi.org\/10.1007\/s11912-000-0025-9","relation":{},"ISSN":["1523-3790","1534-6269"],"issn-type":[{"value":"1523-3790","type":"print"},{"value":"1534-6269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,7]]}}}